HERON THERAPEUTICS, INC. /DE/ (HRTX) Return On Equity % [USD] 2012 - 2024

Historical data

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Heron Therapeutics, Inc. /De/ quarterly/annual Return On Equity history and growth rate from 2012 to 2024.
  • Heron Therapeutics, Inc. /De/ Return On Equity for the quarter ending March 31, 2024 was 240 %.
  • Heron Therapeutics, Inc. /De/ annual Return On Equity for 2023 was 393 %.
  • Heron Therapeutics, Inc. /De/ annual Return On Equity for 2022 was -1.9 K %, a 1092% decline from 2021.
  • Heron Therapeutics, Inc. /De/ annual Return On Equity for 2021 was -160 %, a 111% decline from 2020.
Return On Equity, Quarterly (% [USD])
Return On Equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q1 2024 240 +21.4 K Jan 1, 2024 Mar 31, 2024
Q4 2023 393 +2.3 K Oct 1, 2023 Dec 31, 2023
Q3 2023 737 +1.59 K Jul 1, 2023 Sep 30, 2023
Q2 2023 3.72 K +4.18 K Apr 1, 2023 Jun 30, 2023
Q1 2023 -21.1 K -20.9 K -8564% Jan 1, 2023 Mar 31, 2023
Q4 2022 -1.9 K -1.74 K -1092% Oct 1, 2022 Dec 31, 2022
Q3 2022 -848 -720 -561% Jul 1, 2022 Sep 30, 2022
Q2 2022 -458 -350 -325% Apr 1, 2022 Jun 30, 2022
Q1 2022 -244 -156 -176% Jan 1, 2022 Mar 31, 2022
Q4 2021 -160 -84.1 -111% Oct 1, 2021 Dec 31, 2021
Q3 2021 -128 -63.3 -97.2% Jul 1, 2021 Sep 30, 2021
Q2 2021 -108 -50.1 -87.1% Apr 1, 2021 Jun 30, 2021
Q1 2021 -88.3 -31.5 -55.4% Jan 1, 2021 Mar 31, 2021
Q4 2020 -75.6 -13.8 -22.4% Oct 1, 2020 Dec 31, 2020
Q3 2020 -65.1 -4.3 -7.08% Jul 1, 2020 Sep 30, 2020
Q2 2020 -57.5 -0.63 -1.11% Apr 1, 2020 Jun 30, 2020
Q1 2020 -56.9 -7.63 -15.5% Jan 1, 2020 Mar 31, 2020
Q4 2019 -61.7 -6.76 -12.3% Oct 1, 2019 Dec 31, 2019
Q3 2019 -60.8 +11.5 +15.9% Jul 1, 2019 Sep 30, 2019
Q2 2019 -56.9 +55.5 +49.4% Apr 1, 2019 Jun 30, 2019
Q1 2019 -49.2 +191 +79.5% Jan 1, 2019 Mar 31, 2019
Q4 2018 -55 +176 +76.2% Oct 1, 2018 Dec 31, 2018
Q3 2018 -72.2 +313 +81.2% Jul 1, 2018 Sep 30, 2018
Q2 2018 -112 +339 +75.1% Apr 1, 2018 Jun 30, 2018
Q1 2018 -240 +245 +50.6% Jan 1, 2018 Mar 31, 2018
Q4 2017 -231 +240 +51% Oct 1, 2017 Dec 31, 2017
Q3 2017 -385 -167 -76.3% Jul 1, 2017 Sep 30, 2017
Q2 2017 -452 -325 -255% Apr 1, 2017 Jun 30, 2017
Q1 2017 -485 -399 -463% Jan 1, 2017 Mar 31, 2017
Q4 2016 -471 -387 -464% Oct 1, 2016 Dec 31, 2016
Q3 2016 -218 -134 -159% Jul 1, 2016 Sep 30, 2016
Q2 2016 -127 -32.4 -34.1% Apr 1, 2016 Jun 30, 2016
Q1 2016 -86.2 +23.3 +21.3% Jan 1, 2016 Mar 31, 2016
Q4 2015 -83.5 +19.3 +18.8% Oct 1, 2015 Dec 31, 2015
Q3 2015 -84.3 +7.75 +8.42% Jul 1, 2015 Sep 30, 2015
Q2 2015 -94.9 +9.54 +9.13% Apr 1, 2015 Jun 30, 2015
Q1 2015 -110 +28.3 +20.5% Jan 1, 2015 Mar 31, 2015
Q4 2014 -103 +35.7 +25.8% Oct 1, 2014 Dec 31, 2014
Q3 2014 -92.1 +45.4 +33% Jul 1, 2014 Sep 30, 2014
Q2 2014 -104 -10.2 -10.8% Apr 1, 2014 Jun 30, 2014
Q1 2014 -138 -60.3 -77.7% Jan 1, 2014 Mar 31, 2014
Q4 2013 -138 -43.4 -45.7% Oct 1, 2013 Dec 31, 2013
Q3 2013 -137 -21.2 -18.2% Jul 1, 2013 Sep 30, 2013
Q2 2013 -94.2 +85.9 +47.7% Apr 1, 2013 Jun 30, 2013
Q1 2013 -77.6 +65.1 +45.6% Jan 1, 2013 Mar 31, 2013
Q4 2012 -95 Oct 1, 2012 Dec 31, 2012
Q3 2012 -116 Jul 1, 2012 Sep 30, 2012
Q2 2012 -180 Apr 1, 2012 Jun 30, 2012
Q1 2012 -143 Jan 1, 2012 Mar 31, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.